Narrow search
Showing 1 - 10 of 12
Cover Image
The Impact of Public and Private Research Support on Premature Cancer Mortality and Hospitalization in the U.S., 1999-2013
Lichtenberg, Frank R. - 2017
We use data from PubMed and other sources to examine the impact of public and private research support on premature (before ages 75, 65, and 55) cancer mortality and hospitalization, by estimating difference-in-differences models based on longitudinal, cancer-site-level data on about 30 cancer...
Persistent link: https://www.econbiz.de/10012960774
Cover Image
The impact of public and private research support on premature cancer mortality and hospitalization in the U.S., 1999-2013
Lichtenberg, Frank R. - 2017
Persistent link: https://www.econbiz.de/10011635206
Cover Image
The Impact of Public and Private Research Support on Premature Cancer Mortality and Hospitalization in the U.S., 1999-2013
Lichtenberg, Frank R. - 2017
The estimates indicate that cancer sites about which more research-supported articles were published since the 1970s had larger reductions in premature mortality and hospitalization during the period 1999-2013, controlling for the change in the number of people diagnosed. Cancer sites for which...
Persistent link: https://www.econbiz.de/10012455440
Cover Image
Spurious correlation in estimation of the health production function: A note
Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009
contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …
Persistent link: https://www.econbiz.de/10010315553
Cover Image
Spurious correlation in estimation of the health production function: A note
Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009
contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …
Persistent link: https://www.econbiz.de/10010285825
Cover Image
Response to Baker and Fugh-Berman's critique of my paper, "Why has longevity increased more in some states than in others?"
Lichtenberg, Frank R. - 2009
innovation accounts for a substantial portion of recent increases in U.S. life expectancy. Baker and Fugh-Berman claim that my … literature. Baker and Fugh-Berman express deep skepticism about my study's conclusion that medical innovation has played a very …
Persistent link: https://www.econbiz.de/10003861794
Cover Image
The impact of recent chemotherapy innovation on the longevity of Myeloma patients : U.S. and international evidence
Lichtenberg, Frank R.; Hostenkamp, Gisela - 2013
important innovations since 1997. We investigate the impact of recent chemotherapy innovation on the longevity of myeloma … post-1997 chemotherapy innovation did not exceed $45,551. We also investigate the impact of chemotherapy innovation on the …, controlling for other factors. The estimates imply that chemotherapy innovation reduced the age-adjusted myeloma cancer mortality …
Persistent link: https://www.econbiz.de/10010223067
Cover Image
The expanding pharmaceutical arsenal in the war on cancer
Lichtenberg, Frank R. - 2004
Persistent link: https://www.econbiz.de/10001966562
Cover Image
The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients : U.S. and International Evidence
Lichtenberg, Frank R.; Hostenkamp, Gisela - 2021
important innovations since 1997. We investigate the impact of recent chemotherapy innovation on the longevity of myeloma … post-1997 chemotherapy innovation did not exceed $45,551. We also investigate the impact of chemotherapy innovation on the …, controlling for other factors. The estimates imply that chemotherapy innovation reduced the age-adjusted myeloma cancer mortality …
Persistent link: https://www.econbiz.de/10013315665